Pediatric coronary allograft vasculopathy--a review of pathogenesis and risk factors

Area of Science:

• Cardiology
• Transplantation Immunology
• Pediatric Cardiology

Background:

• Coronary allograft vasculopathy (CAV) is the primary cause of late graft loss in cardiac transplant recipients.
• Pathogenesis involves multifactorial elements including immune response, genetics, metabolism, infection, and immunosuppression.
• Pediatric recipients present unique challenges, including prior sensitization from reconstructive surgery and distinct risk factor profiles.

Purpose of the Study:

• To review current concepts of coronary allograft vasculopathy.
• To summarize confirmed risk factors and their interactions.
• To explore unique clinical findings and characteristics in pediatric transplant recipients.

Main Methods:

• Review of existing literature, primarily from animal models and adult clinical studies.
• Synthesis of current understanding regarding CAV pathogenesis.
• Analysis of pediatric-specific data and clinical observations.

Main Results:

• CAV is multifactorial, influenced by immune, constitutional, genetic, metabolic, and infectious factors, alongside iatrogenic injury.
• Infants and young children exhibit lower CAV rates, potentially due to immune system immaturity.
• Pediatric patients may have pre-existing sensitization from prior cardiac surgeries.

Conclusions:

• Understanding CAV requires considering both general risk factors and pediatric-specific nuances.
• Further research is needed to fully elucidate CAV in pediatric cardiac transplant recipients.
• Immune system immaturity in young children may offer some protection against CAV.